Mitochondrial Dysfunction Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the cell type. See the content below for detailed information.
Mitochondrial dysfunction neurons are neuronal populations characterized by impaired mitochondrial function, leading to energy deficit, oxidative stress, and ultimately cell death. These neurons are central to the pathogenesis of many neurodegenerative diseases.
- Complex I (NADH:ubiquinone oxidoreductase): Often deficient in PD
- Complex III (Cytochrome bc1): Source of ROS
- Complex IV (Cytochrome c oxidase): Impaired in AD
- ATP synthase (Complex V): Reduced ATP production
- PINK1: Kinase that accumulates on damaged mitochondria
- Parkin: E3 ubiquitin ligase for mitophagy
- Mfn1/Mfn2: Fusion proteins
- Drp1: Fission protein
- LC3: Autophagosome marker
- Hippocampal pyramidal neurons
- Complex IV impairment
- High metabolic demand for synaptic plasticity
- Amyloid-β localizes to mitochondria
- Motor neurons
- Large axonal projections require high energy
- Mitochondrial transport defects
- Complex I and IV dysfunction
- mtDNA mutations: Accumulate with age
- Nuclear DNA defects: Inherited metabolic diseases
- Toxin exposure: MPTP, rotenone, 3-NP
- Protein aggregation: Impairs mitochondrial function
- Energy failure: ATP depletion
- ROS overproduction: Oxidative damage
- Calcium dysregulation: Excitotoxicity
- Apoptosis: Intrinsic pathway activation
- Fusion: Sharing of mitochondrial components
- Fission: Generation of new mitochondria
- Transport: Along axons and dendrites
- Mitophagy: Selective degradation
- CoQ10: Electron carrier and antioxidant
- Mitochondrial division inhibitor (mdivi-1): Drp1 inhibitor
- PARP inhibitors: Preserve NAD+ for DNA repair
- Pi3K/PKB activators: Promote mitophagy
- NDUFV1, NDUFV2: Complex I subunits
- PARK2 (Parkin): Gene replacement
- PINK1: Kinase therapy
- CSF lactate (energy deficiency)
- Mitochondrial DNA copy number
- Complex I activity in platelets
The study of Mitochondrial Dysfunction Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Schon, E.A., & Przedborski, S. (2011). Mitochondria. Neuron, 71(5), 819-831.
- Lin, M.T., & Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443(7113), 787-795.
- Winklhofer, K.F., & Haass, C. (2010). Mitochondrial dysfunction in Parkinson's disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1802(1), 29-44.
- Gao, J., et al. (2017). Mitochondrial dysfunction in Alzheimer's disease. Translational Neurodegeneration, 6, 21.
- Corti, O., et al. (2020). The functions of Parkin in mitochondrial quality control. Nature Reviews Neuroscience, 21(9), 535-551.